Product * Biosimilar Ph2 not performed Commercialization preparation Product Process Development Preclinical Phase 1 Phase 2 Phase 3 Marketing Regulatory Approval Recombinant Hyaluronidase (Hybrozyme™) Tergase® Commercialization in Korea MFDS Biosimilars Eyluxvi®/EYZANFY® EU / Korea Marketing Approval MFDS EMA
